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Spinal muscular atrophy: Clinical
spectrum and genetic mutations in
Pakistani children
Shahnaz Ibrahim, Tariq Moatter1, Ali Faisal Saleem
Departments of Pediatrics and Child Health, 1Pathology and Microbiology, Aga Khan University, Karachi, Pakistan

Abstract
Background: In Pakistan the rate of consanguineous marriages is high, thus, the chance
of incidence of autosomal recessive disorders is likely to be high. The aim of this study is
to investigate the clinical characteristics and genetics of spinal muscular atrophy (SMA)
in children who presented to Aga Khan University, Karachi. Materials and Methods: This
study was a retrospective review of the medical charts of children (neonate: 15 years) with
discharge diagnosis of SMA during last 10 years. Demographic features, consanguinity,
and diagnostic analysis (including genetic analysis) were noted. Results: During the study
period 67 children had a discharge diagnosis of SMA. Werdnig Hoffman disease (SMA
type I) was the commonest variant seen in 37 (56%) children. Overall 68% were infants.
High parental consanguinity was observed in 68% of the study cohort. The history of
delayed development and undiagnosed early death was observed in the families of 19
children. Genetic testing was performed in 22 (33%) children. Survival motor neuron (SMN)
1 gene deletion was found in 19 (86%) of the 22 patients in whom the gene analysis
was done and 13 (68%) were also positive for neuronal apoptosis inhibitory proteins
(NAIP) deletion. Conclusion: SMA is not an uncommon neurodegenerative disorder
in Pakistan and SMA type I was the most common type. SMN1 gene deletion was
the most common genetic deletion found in this study. In addition, family history of
developmental delay and frequent early deaths highlights the need for implementation
of prenatal diagnosis for early detection, effective control, and management of this
disorder in Pakistan.
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Introduction
Spinal muscular atrophy (SMA) is a neurodegenerative
disease characterized by progressive degeneration
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of alpha motor neurons, leading to muscle atrophy,
paralysis, and even death.[1] Mostly it has a recessive
inheritance; however, autosomal dominant and X-linked
inheritance has been documented. [2] The reported
incidence is about 1 in 10,000 live births with a carrier
frequency of 1 in 50.[3] The gene for SMA, survival motor
neuron (SMN1) has been mapped on the 5q11.2–13.3
region and there are two copies of SMN gene: SMN1 and
SMN2.[4] Most common mutation found in SMA patients
is homozygous deletion of SMN1 exon 7; however,
many compound heterozygous subjects with different
deletions and point mutation have been documented.[5]
All patients with SMA lack a functioning SMN1 gene
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and are thus dependent on their SMN2 gene for SMN
protein, which is nonfunctional and rapidly degraded,
leading to selective degeneration of spinal and cranial
motor neurons.[6]
Phenotypically SMA has extreme variability and
clinically classified: [7] SMA type I (severe variant,
Werdnig–Hoffman) with age of onset before 6 months,
may not sit, and usually die before their second
birthday; SMA type II (intermediate variant) with age
of onset between 7–18 months, may sit but never stand
and death usually after 2 years of age; SMA type III
(mild variant, Kugelberg–Welander) with age of onset
~18 months of age and death is in adult life; and SMA
type IV (adult varients) presents in the second or third
decade, individuals walk during the adulthood and
death occurs in adult life.[3] There other form is SMA
type 0 or embryonic form (lethal variant), characterized
by reduced fetal movements between 30–36 weeks
of pregnancy with a very short life expectancy.[8] The
clinical characteristics of the disorder are: hypotonia,
symmetrical proximal weakness, atrophy, and reduced
to absent deep tendon reflexes.[4] Genetic diagnosis by
using polymerase chain reaction (PCR)-based DNA
methods have been developed to detect deletions in both
SMN and Neuronal apoptosis inhibitory (NAIP) gene.[2,9]
SMA is an autosomal recessive and consanguineous
marriage increases the risk of the disease in the family.
High prevalence of SMA has been reported in Iran, Egypt,
and Saudi Arabia where consanguineous marriage
rates are high.[10-13] Pakistan has one of the highest
reported consanguineous marriage rate in the world,
approximately 61% marriages.[14] With this high-rate
consanguineous marriage, we expect a high burden of
SMA in Pakistan. This report describes the demographic
features, clinical characteristics, and genetic diagnosis of
children with SMA in the Pakistani population.

Materials and Methods
Identification of study population
This was a retrospective chart review of children
(neonate, 15 years) seen in the last 10 years (January
2001 to December 2010) and children with a diagnosis of
SMA were evaluated. The sources of subjects included
in this study were (i) inpatients discharge records with a
diagnosis of SMA, ICD code (International Classification
of Disease, 2008 (ICD9) 335.1 and 335.1 and (ii) data from
the electrodiagnostic laboratory and genetic laboratory
(SMA gene analysis). This study was approved by
the Institutional ethical review committee; Aga Khan
University, Karachi.
Case definition
Diagnosis of SMA was considered in any child with
generalized hypotonia, diffuse symmetrical proximal
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muscle weakness and atrophy, tremor of fingers and
hands, tongue fasciculation along with absent or greatly
decreased deep tendon reflexes[4] and electromyographic
(EMG) evidence of denervation, preganlionic anterior
horn cells. [3] Molecular genetic testing was aimed
at detecting bi-allelic deletions or mutations in the
survival motor neuron 1 (SMN1) gene on chromosome
5q13 (exon 7 and exon 8) and/or neuronal apoptosis
inhibitory protein (NAIP) gene. Muscle biopsy was not
done in any of the patients.
Gene analysis
Genomic deoxyribonucleic acid (DNA) was isolated
from blood samples using column based DNA extraction
kit obtained from Promega (USA). Deletion of exon 7
and 8 of SMN 1 gene was examined by polymerase
chain reaction (PCR) amplification and restriction
endonuclease digestion according to the method of
Steege et al.[15] PCR amplification was carried out for
35 cycles in PCR mixture containing 100 ng DNA, 75 ng
of each primer, 200 μM of dNTPs, 1.5 MgCl2, 2.5U Taq
polymerase in a final volume of 50 μL. PCR products of
exon 7 were digested with Dra I, and exon 8 with DdeI.
The digestion pattern of the PCR product was evaluated
according to the protocol described by Steege et al.[15]
The deletion of exon 5 of NAIP was identified by using
the method described by Roy et al.[16] Along with exon 5;
exon 13 of NAIP was also amplified and used a control
to monitor the performance of PCR assay.
Statistical analysis
The retrieved data were analyzed on SPSS version 19.
Demographic features included age in days, weight,
gender, presenting complaint at admission or health
seeking, year of admission, consanguinity, perinatal
depression, developmental delay or any other
early death/s within the family were retrieved.
Electromyography and nerve conduction study (EMG/
NCV) and genetic analysis data were also retrieved and
reported. SMN and NAIP gene mutations were reported
among positive patients. Because of descriptive nature of
the data only frequency and percentages were calculated.

Results
After chart review during the study period 67 children
who fulfilled the inclusion criteria. Of the 67 patients
42 (63%) were infants and 7 were neonates. There was
male predominance, 38 (57%) and male to female ratio
was 1.2:1. Children were further divided according to
the SMA types 1 to 3 [Table 1]. Developmental delay
was the main presenting feature (45%) followed by,
generalized weakness, hypotonia and respiratory
difficulty. SMA type I accounted for 56% (n=37) of
the cohort. Mean age at presentation in SMA-type
1 was 3.3±1.7 months (median; 3 months). Overall
295
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Table 1: Baseline features and genetic identification of children
with spinal muscular atrophy

Variables^

SMA type 1* SMA type 2*
(n = 37)
(n = 15)

Mean age of
3.3 ± 1.7 mo
presentation (± SD)
Male
23 (62%)
Main presenting
complaint
Respiratory difficulty
10
Developmental delay
14
-Failure to thrive
Weakness / Hypotonia
7
Walking difficulty
-Fever/ Lethargy/
6
Sepsis/ Poor intake
Weight <5th centile
10 (33%)
Consanguinity in
21 (66%)
parents
Perinatal depression
12 (35%)
Positive family history
Diagnosed SMA/
12 (55%)
Developmental delay
14 (47%)
Early deaths
Genetic analysis of SMA
patients
Exon 7 and 8 deleted in
2
SMN 1 gene
Both NAIP and SMN 1
10
gene deleted
Negative
1

SMA type
3*(n = 15)

15 ± 4 mo

70 ± 2 mo

6 (40%)

9 (60%)

1
7
1
4
-1

-9
-5
1
--

3 (40%)
9 (82%)

5 (36%)
6 (60%)

6 (54%)

2 (15%)

4 (50%)
3 (27%)

3 (40%)
2 (18%)

--

4

3

--

1

1

*Adapted from reference(6) ^Because of missing values the data, the denominator
was changed for each subcategory. Spinal muscular atrophy (SMA); survival
motor neuron (SMN); neuronal apoptosis inhibitory (NAIP).

18 (31%) children were severely malnourished (weight
for age; <5 th percentile). The history of parental
consanguinity was present in 53 (73%) children
and them 36 (68%) had consanguineous marriages
[Figure 1]. Perinatal depression was positive among
20 (34%) on the 58 children where such history was
documented; while family history of developmental
delay and/or spinal muscular atrophy was found
in 19 (45%) of 42 children where such history was
documented. The history of early deaths in the family
was present in 19 (37%) of the 52 children with the
data available. EMG/nerve conduction studies were
performed in 62 patients, showing positive sharp
waves, fibrillation, and/or fasciculation in all, and were
consistent with the diagnosis of SMA.
Gene analysis was done in 22 children; among them 19
were positive (86%), genetic testing results were negative
in 3 (13%) children. All positive patients showed a
deletion of exon 7 and 8 in SMN1 gene. Exon 5 deletion
of NAIP gene was also found positive in 13 (68%) of the
19 patients [Table 1]. Out of 20 hospitalized patients
5 (25%) children died. All died because of respiratory
failure and were diagnosed as SMA type 1. The mean
age at death was 3.9±1.2 months.
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Discussion
Werdnig–Hoffman disease (SMA-1) is the most severe
clinical type of SMA and prenatal onset of SMA has also
been defined.[10,17] It is associated with high morbidity
and mortality. In our study majority of patients (61%)
were infants at the time of presentation similar to the
observations in other studies.[10,17,18] Males had a slightly
higher preponderance than females in our study
and this also has been reported in the literature.[10,17]
Consanguinity was very high in our study. The reported
consanguinity in the earlier studies ranged between
38.9% and 49%.[10,17,19] High consanguinity would reflect
the autosomal recessive inheritance of this disease.
Table 2 compares the consanguinity rates among SMA
children from different countries. Early or previous
deaths in family and history of developmental delay
may be the additional features indicating a genetic
background of this disease in our study cohort.
More than 98% of patients with spinal muscular atrophy
have a homozygous disruption of SMN1 by deletion,
rearrangement, or mutation.[3] The clinical severity is
influenced by the number of copies of SMN2 gene. It
has been observed that 95% of SMA type I patients have
only 1-2 copies of SMN2, whereas almost all patients
belonging to type III had 3 or more copies.[20] Because
of this, the children belonging to these groups have less
severe form of disease.[21] The most common deletion
found in our cohort was of SMN1. Exon 7 and 8 in
SMN1gene was deleted in majority of positive children.
Similar was the observation in the Egyptian cohort, in
this study the frequency of homozygous deletion of exon
7 and 8 were present in 54.5–80% of patients irrespective
of their clinical severity.[22] In our cohort NAIP was the
most common deletion (68%) among children tested for
genetic testing; 10 (77%) of them were SMA type 1. The
frequency of NAIP deletion was also found to be more
frequent in SMA type I (80%) as compared to type II
(22%) and type III (50%) in the Egyptian cohort.[22]
However, the incidence was much higher (100%) in the
studies from Kuwait and Saudi Arabia.[10,13] Interestingly
all the three children with SMA II in our study had gene
deletion for both NAIP and SMN1 gene. The reported
frequency of NAIP deletion is relatively lower for both
SMA II and III.[17,23] Very few children with SMA II
and SMA III had genetic testing and therefore we are
unable to draw any significant conclusion from these
results. Larger samples are needed to further explain
the genetic basis of SMA type II and III patients in
our population. Genetic testing was negative in three
children. The 5q-SMA genetic testing is 95% sensitive
and 100% specific.[23] Fiver percent (1/20) of affected
individuals with 5q-SMA have rare point mutation that
are not detected by the SMN genetic testing. Most of
these children have one SMN1 gene with SMN1 exon 7
Neurology India | May-Jun 2012 | Vol 60 | Issue 3
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Figure 1: Family tree of a patient with SMA I

Table 2: Comparison of reported proportion of parental
consanguinity in children with SMA

Author name and
study year
Shawky (2011)[10]
Koul (2007)[17]
Salahshourifar (2007)[12]
Al Rajeh (1998)[13]
Ibrahim et al. (our study)

Reported
proportion of
consanguinity
46%
49%
65%
81%
68%

Country

Egypt
Oman
Iran
Saudi Arabia
Pakistan

missing and a second SMN1 gene with a rare point
mutation.[23]
Currently there is no available cure for SMA; one possible
intervention could be to reduce the consanguinity by
educating the population. This will eventually interrupt
the transmission by reducing carrier state. With the
availability of genetic testing it is now possible to
diagnose these children early so that appropriate
counseling can be given to the family on the risk of
future pregnancies. Early identification by genetic
testing has also opened the way for early antenatal
diagnosis.
Limitations
Genetic testing for SMA in our university was started
from 2005; hence, data on genetic testing were only
present for patients after this period. Some families
denied genetic testing due to various reasons. With
these limitations this is the first study from Pakistan
that reports clinical spectrum and genetic testing of
SMA patients.
Neurology India | May-Jun 2012 | Vol 60 | Issue 3

Conclusion
SMA-1 is the commonest SMA type in our study
population. Deletion of exon 7 and exon 8 in SMN1 gene
is the commonest deletion in our SMA study cohort;
however, an exon 5 deletion in NAIP gene is also very
high. This study highlights the need for implementation
of prenatal diagnosis in high risk consanguineous
populations like Pakistan to reduce the burden of the
disease.
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